<i>GRIN2A</i> and Schizophrenia: Scientific Evidence and Biological Mechanisms.

Curr Neuropharmacol · 2025 · PMC12163467 · PMID 39501956

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Compared with control subjects, the (GT)n polymorphism in the promoter of GRIN2A showed marginally significant allelic differences in patients with schizophrenia, which reduced the expression of GRIN2A [ 100 ].

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.